Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysis.

Saved in:
Bibliographic Details
Title: Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysis.
Authors: Sterrenburg MD (AUTHOR), Veltman-Verhulst SM (AUTHOR), Eijkemans MJ (AUTHOR), Hughes EG (AUTHOR), Macklon NS (AUTHOR), Broekmans FJ (AUTHOR), Fauser BC (AUTHOR)
Source: Human Reproduction Update. Mar2011, Vol. 17 Issue 2, p184-196. 13p.
Database: Academic Search Ultimate
Description
ISSN:13554786